Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

Please provide your email address to receive an email when new articles are posted on . Although we use all of the modern presbyopic IOLs In our practice, two lens types now dominate our presbyopic ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Current preoperative and intraoperative technologies are enabling better toric IOL implantation ...

First Preloaded Toric Available in the United States and Monofocal Option Combine Consistent IOL Delivery with Outstanding Visual Outcomes of enVista® LAVAL, QC, Oct. 27, 2020 /PRNewswire/ -- Bausch + ...

A cataract (cloudy eye lens) blocks light from reaching the retina, which helps the brain process sight. Cataracts develop over time, gradually leading to blurry, hazy vision and affecting daily ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S. Food ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...